marianne saevik - Infectious Diseases

Author Information

Marianne Sævik is affiliated with the Division for Infectious Diseases, Department of Medicine, at Haukeland University Hospital in Bergen, Norway. Her work predominantly focuses on infectious diseases, with a significant emphasis on the study and understanding of COVID-19 and other viral infections. Her research contributions are crucial in understanding the immune responses and epidemiology of infectious diseases.

Research Contributions

Marianne Sævik has made substantial contributions in the field of infectious diseases, particularly focusing on COVID-19 and its impact. Her research encompasses the development of rapid antibody screening tests for SARS-CoV-2 variants, investigation of COVID-19 attack rates, and the long-term effects of COVID-19 on patients. She has also explored immune responses to influenza and enterotoxigenic Escherichia coli in human challenge models, contributing to vaccine development and infectious disease management.

Aliases

There are no listed aliases for Marianne Sævik.

Publication and Citation Metrics

Metric	Value
Number of Papers	14
Citation Count	640
H-index	8

Publications:

A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern

DOI: 10.1038/s43856-022-00091-x

Year: 2022

Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: A case-ascertained study

DOI: 10.1016/j.lanepe.2020.100014

Year: 2021

Long COVID affects home-isolated young patients

DOI: 10.21203/RS.3.RS-238339/V1

Year: 2021

Long COVID in a prospective cohort of home-isolated patients

DOI: 10.1038/s41591-021-01433-3

Year: 2021

SARS-CoV-2–Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study

DOI: 10.1093/infdis/jiaa737

Year: 2020

Experimental Infection of Human Volunteers with the Heat-Stable Enterotoxin-Producing Enterotoxigenic Escherichia coli Strain TW11681

DOI: 10.3390/pathogens8020084

Year: 2019

A new human challenge model for testing heat-stable toxin-based vaccine candidates for enterotoxigenic Escherichia coli diarrhea – dose optimization, clinical outcomes, and CD4+ T cell responses

DOI: 10.1371/journal.pntd.0007823

Year: 2019

Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study

DOI: 10.1093/cid/ciy487

Year: 2019

Experimental infection of healthy volunteers with enterotoxigenic Escherichia coliwild-type strain TW10598 in a hospital ward

DOI: 10.1186/1471-2334-14-482

Year: 2014

Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial.

DOI: 10.1016/j.vaccine.2011.08.042

Year: 2011

What Research is Being Conducted on Apicoplasts?

Why is Biosecurity Important?

What is Viral Mutation and Why is it Important?

What Are the Components of the DTaP Vaccine?

How Do Extreme Weather Events Impact Infectious Disease Spread?

How Can Salmonella Infections be Prevented?

What are the challenges in HIV prevention?

Why is Fatty Acid Synthesis Important in Infectious Diseases?

Why is Awareness Important?

How Does Glycolysis Relate to Infectious Diseases?

Partnered Content Networks

Relevant Topics